After starting out as a London chemist (pharmacy) store owned by William Martindale, Martindale Pharma has been in business for more than a century. The company’s reputation as a leading UK manufacturer and supplier of prescription pharmaceutical products for healthcare professionals working in both Primary and Secondary Care has grown steadily over that time and Martindale Pharma is now firmly established as a leading supplier to the NHS in the UK and exports its products to a number of other major pharmaceutical markets.
In May 2010 AAC Capital bought Martindale Pharma from Cardinal Health. AAC Capital continues to develop the business and pursue growth opportunities. Martindale Pharma has built strong relationships with prescribers and influencers on drug choice in its chosen business segments (see below). Working on the basis of a partnership, Martindale Pharma’s enviable list of key customers includes Alliance Boots (Alliance Healthcare and Boots), Celesio (AAH and Lloyds), Co-Operative Pharmacies and the NHS, particularly the Commercial Medicines Unit. Our operating philosophy is one of close co-operation and responsiveness to customer needs.
At Martindale Pharma we manufacture the majority of our products at our own facilities in the UK. In total the company produces and packs c.50 million doses a year in a range of formats including sterile ampoules/vials, oral solutions, pre-filled syringes, suppositories, tablets and ophthalmic drops and ointments. Martindale Pharma now employs over 430 people, including a UK commercial team of over 50 people.
Key Business Segments
Martindale Pharma’s Specials expertise gives us the ability to manufacture over 30,000 products in a range of formulations. Handling around 700 orders for these highly personalised medicines a day the vast majority of products made by our dedicated team of pharmacists and pharmacy technicians are supplied to the pharmacy within 24 hours of ordering. We are one of the market leading companies in this Business Segment.
Martindale Pharma manufacture and market the Aurum Range, the UK’s leading range of 11 pre-filled syringes for emergency use by resuscitation and operating theatre teams. We also manufacture and market a Caffeine product for treatment of Apnoea of Prematurity, a critical care area in neonatology. In both areas we are the leading company.
Martindale Pharma provides a broad range of both diagnostic and therapeutic ophthalmic products as generic, own label and third party brands, we are one of the leading suppliers in our chosen disease areas for ophthalmics.
Hospital Specialty Products
Martindale’s range of, principally parenteral, products are used in a wide range of hospital situations. We are one of the country’s leading manufacturers of sterile injection products making over 25 million ampoules a year.
Martindale is ranked number one in market share in the opiate addiction market – driven by the success of our brand Physeptone, the UK’s leading methadone product. We work in partnership with NHS, Community Drug Teams and pharmacies to ensure that drug service users receive the optimum support as they seek to move away from the use of illicit opioids.
Martindale Pharma is actively seeking to add to its product portfolio for the UK market, we are actively looking to acquire or license additional products that match our key Business Segments.